These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


236 related items for PubMed ID: 22035373

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X, Carver B, Coleman J, Lovelock M, Hunt M.
    Int J Radiat Oncol Biol Phys; 2012 Sep 01; 84(1):125-9. PubMed ID: 22330997
    [Abstract] [Full Text] [Related]

  • 3. Role of principal component analysis in predicting toxicity in prostate cancer patients treated with hypofractionated intensity-modulated radiation therapy.
    Vesprini D, Sia M, Lockwood G, Moseley D, Rosewall T, Bayley A, Bristow R, Chung P, Ménard C, Milosevic M, Warde P, Catton C.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):e415-21. PubMed ID: 21477939
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Outcome and toxicity for patients treated with intensity modulated radiation therapy for localized prostate cancer.
    Vora SA, Wong WW, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.
    J Urol; 2013 Aug 15; 190(2):521-6. PubMed ID: 23415964
    [Abstract] [Full Text] [Related]

  • 7. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
    Fonteyne V, De Gersem W, De Neve W, Jacobs F, Lumen N, Vandecasteele K, Villeirs G, De Meerleer G.
    Int J Radiat Oncol Biol Phys; 2009 Nov 15; 75(4):1013-20. PubMed ID: 19386427
    [Abstract] [Full Text] [Related]

  • 8. Analysis of toxicity in patients with high risk prostate cancer treated with intensity-modulated pelvic radiation therapy and simultaneous integrated dose escalation to prostate area.
    Arcangeli S, Saracino B, Petrongari MG, Gomellini S, Marzi S, Landoni V, Gallucci M, Sperduti I, Arcangeli G.
    Radiother Oncol; 2007 Aug 15; 84(2):148-55. PubMed ID: 17692416
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
    Lim TS, Cheung PC, Loblaw DA, Morton G, Sixel KE, Pang G, Basran P, Zhang L, Tirona R, Szumacher E, Danjoux C, Choo R, Thomas G.
    Int J Radiat Oncol Biol Phys; 2008 Sep 01; 72(1):85-92. PubMed ID: 18355982
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pelvic nodal dose escalation with prostate hypofractionation using conformal avoidance defined (H-CAD) intensity modulated radiation therapy.
    Hong TS, Tomé WA, Jaradat H, Raisbeck BM, Ritter MA.
    Acta Oncol; 2006 Sep 01; 45(6):717-27. PubMed ID: 16938815
    [Abstract] [Full Text] [Related]

  • 13. Pilot study of conformal intensity modulated radiation therapy for localized prostate cancer.
    Aillères N, Azria D, Thézenas S, Barbier N, Fenoglietto P, Delard R, Hay MH, Dubois JB.
    Cancer Radiother; 2004 Apr 01; 8(2):59-69. PubMed ID: 15063872
    [Abstract] [Full Text] [Related]

  • 14. Comparative toxicity and dosimetric profile of whole-pelvis versus prostate bed-only intensity-modulated radiation therapy after prostatectomy.
    Deville C, Vapiwala N, Hwang WT, Lin H, Ad VB, Tochner Z, Both S.
    Int J Radiat Oncol Biol Phys; 2012 Mar 15; 82(4):1389-96. PubMed ID: 21664069
    [Abstract] [Full Text] [Related]

  • 15. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ, Fuks Z, Hunt M, Lee HJ, Lombardi D, Ling CC, Reuter VE, Venkatraman ES, Leibel SA.
    J Urol; 2001 Sep 15; 166(3):876-81. PubMed ID: 11490237
    [Abstract] [Full Text] [Related]

  • 16. Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer.
    Zelefsky MJ, Levin EJ, Hunt M, Yamada Y, Shippy AM, Jackson A, Amols HI.
    Int J Radiat Oncol Biol Phys; 2008 Mar 15; 70(4):1124-9. PubMed ID: 18313526
    [Abstract] [Full Text] [Related]

  • 17. Radiation dose escalation for localized prostate cancer: intensity-modulated radiotherapy versus permanent transperineal brachytherapy.
    Wong WW, Vora SA, Schild SE, Ezzell GA, Andrews PE, Ferrigni RG, Swanson SK.
    Cancer; 2009 Dec 01; 115(23):5596-606. PubMed ID: 19670452
    [Abstract] [Full Text] [Related]

  • 18. The normal tissue sparing obtained with simultaneous treatment of pelvic lymph nodes and bladder using intensity-modulated radiotherapy.
    Søndergaard J, Høyer M, Petersen JB, Wright P, Grau C, Muren LP.
    Acta Oncol; 2009 Dec 01; 48(2):238-44. PubMed ID: 18759144
    [Abstract] [Full Text] [Related]

  • 19. Clinical impact of margin reduction on late toxicity and short-term biochemical control for patients treated with daily on-line image guided IMRT for prostate cancer.
    Crehange G, Mirjolet C, Gauthier M, Martin E, Truc G, Peignaux-Casasnovas K, Azelie C, Bonnetain F, Naudy S, Maingon P.
    Radiother Oncol; 2012 May 01; 103(2):244-6. PubMed ID: 22119374
    [Abstract] [Full Text] [Related]

  • 20. No impairment of quality of life 18 months after high-dose intensity-modulated radiotherapy for localized prostate cancer: a prospective study.
    Marchand V, Bourdin S, Charbonnel C, Rio E, Munos C, Campion L, Bonnaud-Antignac A, Lisbona A, Mahé MA, Supiot S.
    Int J Radiat Oncol Biol Phys; 2010 Jul 15; 77(4):1053-9. PubMed ID: 19880259
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 12.